ROSELABS logo

Roselabs Finance Ltd

ROSELABS·BSE·
₹20.88▲ +0.98 (+4.92%)
Market Cap20.88 Cr
PE Ratio-74.80
Volume2,748
Day High - Low20.89 - 20.88
52W High-Low28.22 - 16.77

Roselabs Finance Ltd (ROSELABS): company summary

The company's annual revenue rose 70.4% to ₹1 crore, but annual net profit remained at a loss of ₹0 crore.

Roselabs Finance Ltd (ROSELABS) is a micro-cap Financial Services company valued at ₹21 crore operating in Other Financial Services on the NSE and BSE.

Recent price move
Roselabs Finance Ltd last traded at ₹20.88, up 4.92% on the day.
Recent developments
On 2026-09-30, the promoter holding was reported at 74.25%, with no changes noted in foreign or domestic institutional holdings. The company reported a net loss of ₹0 crore in its latest financial year ending 2026-03-31, consistent with previous quarters.
Financial performance
The company's annual revenue rose 70.4% to ₹1 crore, but annual net profit remained at a loss of ₹0 crore. The latest quarter showed no revenue or profit, with the loss widening from ₹0 crore to ₹0 crore compared to the same quarter a year earlier. The net profit margin improved from -41.1% to -25.4%, but return on capital employed remained at -500.0%.
Valuation multiples
A price-to-earnings ratio is not meaningful here because the company is loss-making; the stock trades at -4.60 times book value.
Things to watch
The company has reported a net loss of ₹0 crore for the latest financial year, with no revenue or profit in the latest quarter. The return on capital employed is at -500.0%, indicating significant financial strain. The stock is 29.5% below its 52-week high.
Where it stands
The company remains in a loss position with no revenue or profit in the latest quarter. The net loss remained at ₹0 crore, and the stock is 29.5% below its 52-week high. The return on capital employed is at -500.0%, highlighting ongoing financial challenges.

Summarised by DocStoX's model on 2026-10-18 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.

DocStoX Score
2.5/10
Poor
Fair Value
Sign in to see
ROE
6.10%
Weak
P/E
-74.80x
Loss-making
Debt / Equity
—
Industry
Financial Services
Other Financial Services
Overall View
Mixed

Price performance

Day₹20.88
₹20.89
52W₹16.77
₹28.22
DocStoX take

Supported by growth (7.5), but held back by quality (0.1). Growth looks strong at 7.5, but that is offset by quality at 0.1 and momentum at 3.0. We are calling it Mixed rather than resolving the conflict for you. Scored on 4 of 5 measures.

DocStoX score

Low confidence
2.5
/10
Poor
Quality
Weak
ROE 6.1%
Valuation
No data
Loss-making — no meaningful P/E
Growth
Strong
Revenue +49.9% 5Y CAGR
Risk
Moderate
D/E -1.01 (lender)
Momentum
Soft
36% of 52-week range

Scored on 4 of 5 measures — the rest have no data for this company.

At a glance

Market Cap
₹21 Cr
52W High / Low
₹28 / ₹17
Dividend Yield
0.00%
Promoter Holding
74.25%
EPS (TTM)
₹-0.31
Book Value
—

Key highlights

  • Revenue compounding 50% a year
  • Loss-making — no meaningful P/E
  • Loss-making in some of the last 5 years
1 Positive4 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Financial Services stocks · Other Financial Services

Roselabs Finance Ltd peers in Financial Services

Other Financial Services stocks on the NSE & BSE. See the full Financial Services sector list.